ea0098c31 | Clinical – Nuclear Medicine/Interventional Radiology/Imaging | NANETS2023
Al-Ward Ruaa
, Balderrama Brondan Vania
, Sawani Sahar
, Bassett Roland
, Xu Guofan
, Waguespack Steven G.
, Varghese Jeena
, Amir Habra Mouhammed
, Lu Yang
, Jimenez Camilo
Background: Metastatic pheochromocytomas and paragangliomas are rare neuroendocrine tumors with limited treatment options. We studied the efficacy and safety of off-label High-Specific-Activity I-131-meta-iodobenzylguanidine (HSA-I-131-MIBG) in routine clinical practice. Methods: This is a retrospective cohort study. The primary endpoint is objective response rate (ORR) as per RECIST v1.1. Secondary endpoints are blood pressure control, safety, overall a...